Rifampicin-resistant TB: An inflection point in antimicrobial resistance.

Rifampicin-resistant TB requires urgent integration into the global antimicrobial resistance response through diagnostics, surveillance, and treatment optimization.

• Why it matters: Addressing rifampicin-resistant TB is critical because it represents a significant challenge to controlling antimicrobial resistance and improving patient outcomes worldwide.
• What they did: The authors advocate for incorporating rifampicin-resistant TB into existing AMR strategies by enhancing diagnostic methods, surveillance systems, and developing optimized treatment regimens.
• The result: This integration may improve detection, monitoring, and management of rifampicin-resistant TB, potentially curbing its spread and impact on global health efforts.